Welcome to PracticeUpdate! We hope you are enjoying temporary access to this content.
Please register today for a free account and gain full access
to all of our expert-selected content.
Already Have An Account? Log in Now
ESMO 2019: Recommendations From Dr. David Henry
Dr. David Henry, member of the Advisory Board of PracticeUpdate Oncology, recommends the following presentations at the forthcoming European Society for Medical Oncology (ESMO) 2019 Congress, which will take place from September 27–October 1 in Barcelona.
Friday, September 27, 2019
2:00 PM–3:30 PM Proffered Paper Session
Gastrointestinal Tumors, Non-Colorectal
LBA38_PR CheckMate 459: A Randomized, Multi-Center Phase 3 Study of Nivolumab (NIVO) vs Sorafenib (SOR) as First-Line (1L) Treatment in Patients (pts) With Advanced Hepatocellular Carcinoma (aHCC). T Yau
Friday, September 27, 2019
4:00 PM–5:30 PM Proffered Paper Session
NSCLC, Metastatic
LBA80 Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) for metastatic NSCLC: tissue TMB (tTMB) and outcomes in KEYNOTE-021, 189, and 407. RS Herbst
Friday, September 27, 2019
4:00 PM–5:30 PM Proffered Paper Session
Gynecological Cancers
LBA58 BAROCCO: A randomized phase II study of weekly paclitaxel vs. cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resistant ovarian cancer (PROC). N Colombo
Saturday, September 28, 2019
12:00 PM–1:00 PM Poster Display Session
1814P The use of intravenous ferric carboxymaltose without erythropoiesis-stimulating agents in the treatment of anemia in cancer patients undergoing chemotherapy with or without radiotherapy. H Abdel-Razeq